David van Hoytema

David van Hoytema currently serves as the Chief Executive Officer at FitForMe, a position held since February 2024. Prior to this role, David was the CFO at Cerba Research from February 2022 to December 2022, where responsibilities included integrating the acquisition of Viroclinics and enhancing the finance function. David has extensive experience as CFO at Viroclinics Biosciences BV from September 2017 to December 2022, contributing to advancements in diagnostics and drug testing. Previous roles include Managing Director at Birdseye Advisors, co-founder at Versa, and various leadership positions at Metrological Group, Seatwave, and Skelper. David began a career in finance at TNT and Julius Baer after earning a Master of Law degree in Tax Law from Leiden University.